A Study of the Abuse Liability Potential of ALKS 5461 in Healthy, Non-Dependent, Recreational Opioid Users

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

March 31, 2015

Primary Completion Date

September 30, 2015

Study Completion Date

September 30, 2015

Conditions

Healthy

Interventions

DRUG

ALKS 5461

Sublingual tablets, single administration

DRUG

Buprenorphine

Sublingual tablets, single administration

DRUG

Placebo

Sublingual tablets, single administration

Trial Locations (1)

Alkermes Investigational Site, Overland Park